Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients
Alimentary Pharmacology&Therapeutics, EarlyView.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: H. J. Tsai
,
Y. W. Chuang
,
S. W. Lee
,
C. Y. Wu
,
H. Z. Yeh
,
T. Y. Lee Source Type: research
More News: Chronic Kidney Disease | Drugs & Pharmacology | Hepatitis | Hepatitis B | Urology & Nephrology | Viread